Compare PROF & TLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PROF | TLS |
|---|---|---|
| Founded | N/A | 1969 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 238.1M | 317.1M |
| IPO Year | 2017 | 2020 |
| Metric | PROF | TLS |
|---|---|---|
| Price | $6.95 | $4.44 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $12.00 | $7.90 |
| AVG Volume (30 Days) | 83.4K | ★ 417.9K |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 25.89 | ★ 31.51 |
| EPS | ★ 1.41 | N/A |
| Revenue | $16,098,000.00 | ★ $164,805,000.00 |
| Revenue This Year | $92.40 | $18.72 |
| Revenue Next Year | $64.10 | $14.62 |
| P/E Ratio | $4.83 | ★ N/A |
| Revenue Growth | 50.73 | ★ 52.21 |
| 52 Week Low | $3.92 | $1.83 |
| 52 Week High | $8.95 | $8.36 |
| Indicator | PROF | TLS |
|---|---|---|
| Relative Strength Index (RSI) | 56.97 | 53.90 |
| Support Level | $5.75 | $3.84 |
| Resistance Level | $7.07 | $4.61 |
| Average True Range (ATR) | 0.40 | 0.17 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 74.07 | 69.15 |
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.
Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats. Its business has two reportable and operating segments namely Security Solutions and Secure Networks. The Security Solutions segment focuses on cybersecurity, cloud, and identity solutions, and the Secure Networks focuses on enterprise security. The company derives maximum revenue from the Security Solutions segment.